See more : Guanfu Holding Co., Ltd. (002102.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Danaher Corporation (DHR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danaher Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Schmitt Industries, Inc. (SMIT) Income Statement Analysis – Financial Results
- Presto Automation, Inc. (PRSTW) Income Statement Analysis – Financial Results
- New Hope Dairy Co., Ltd. (002946.SZ) Income Statement Analysis – Financial Results
- FFW Corporation (FFWC) Income Statement Analysis – Financial Results
- Yamaura Corporation (1780.T) Income Statement Analysis – Financial Results
Danaher Corporation (DHR)
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.89B | 31.47B | 29.45B | 22.28B | 17.91B | 19.89B | 18.33B | 16.88B | 20.56B | 19.91B | 19.12B | 18.26B | 16.09B | 13.20B | 11.18B | 12.70B | 11.03B | 9.60B | 7.98B | 6.89B | 5.29B | 4.58B | 3.78B | 3.78B | 3.20B | 2.91B | 2.05B | 1.81B | 1.49B | 1.29B | 1.07B | 949.00M | 831.60M | 840.00M | 749.10M | 714.60M | 615.00M | 446.00M | 298.00M |
| Cost of Revenue | 9.86B | 12.52B | 11.50B | 9.81B | 7.93B | 8.79B | 8.14B | 7.55B | 9.80B | 9.47B | 9.16B | 8.85B | 7.91B | 6.58B | 5.90B | 6.76B | 5.99B | 5.35B | 4.54B | 4.00B | 3.15B | 2.79B | 2.34B | 2.17B | 1.83B | 1.71B | 1.31B | 1.17B | 981.10M | 889.70M | 753.00M | 670.30M | 601.90M | 573.30M | 499.10M | 462.00M | 406.40M | 342.40M | 239.70M |
| Gross Profit | 14.03B | 18.95B | 17.95B | 12.48B | 9.98B | 11.11B | 10.19B | 9.33B | 10.76B | 10.44B | 9.96B | 9.41B | 8.18B | 6.63B | 5.28B | 5.94B | 5.04B | 4.24B | 3.45B | 2.89B | 2.14B | 1.79B | 1.44B | 1.61B | 1.36B | 1.20B | 744.60M | 640.70M | 505.70M | 399.00M | 314.10M | 278.70M | 229.70M | 266.70M | 250.00M | 252.60M | 208.60M | 103.60M | 58.30M |
| Gross Profit Ratio | 58.74% | 60.21% | 60.95% | 55.98% | 55.74% | 55.83% | 55.61% | 55.29% | 52.34% | 52.44% | 52.08% | 51.56% | 50.82% | 50.19% | 47.21% | 46.78% | 45.72% | 44.22% | 43.15% | 41.99% | 40.41% | 39.02% | 38.19% | 42.66% | 42.62% | 41.15% | 36.30% | 35.36% | 34.01% | 30.96% | 29.43% | 29.37% | 27.62% | 31.75% | 33.37% | 35.35% | 33.92% | 23.23% | 19.56% |
| Research & Development | 1.50B | 1.75B | 1.74B | 1.35B | 1.13B | 1.23B | 1.13B | 975.10M | 1.24B | 1.31B | 1.25B | 1.14B | 1.02B | 809.48M | 632.65M | 725.44M | 601.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.25B | 8.52B | 8.20B | 6.90B | 5.59B | 6.47B | 6.04B | 5.61B | 6.05B | 5.70B | 5.43B | 5.18B | 4.61B | 3.67B | 3.19B | 3.35B | 2.71B | 2.74B | 2.18B | 1.80B | 1.32B | 1.09B | 872.68M | 909.90M | 778.40M | 722.10M | 401.60M | 345.90M | 266.90M | 208.50M | 180.20M | 180.60M | 161.60M | 165.50M | 136.90M | 130.40M | 110.60M | 61.30M | 31.60M |
| Other Expenses | 0.00 | -226.00M | 547.00M | 39.00M | 12.00M | 37.20M | 72.80M | 223.40M | 12.40M | 156.50M | 0.00 | 0.00 | 0.00 | 0.00 | -85.12M | 0.00 | -14.34M | -16.38M | 4.60M | -8.14M | -22.50M | 2.78B | 0.00 | 149.72M | 126.40M | 108.70M | 76.10M | 68.60M | 58.50M | 44.60M | 40.90M | 37.10M | 33.20M | 25.60M | 19.10M | 17.60M | 13.50M | 9.30M | 6.80M |
| Operating Expenses | 8.83B | 10.26B | 10.49B | 8.24B | 6.71B | 7.70B | 7.17B | 6.58B | 7.29B | 7.01B | 6.68B | 6.32B | 5.56B | 4.48B | 3.74B | 4.07B | 3.30B | 2.73B | 2.18B | 1.79B | 1.29B | 1.09B | 872.68M | 1.06B | 904.80M | 830.80M | 477.70M | 414.50M | 325.40M | 253.10M | 221.10M | 217.70M | 194.80M | 191.10M | 156.00M | 148.00M | 124.10M | 70.60M | 38.40M |
| Cost & Expenses | 18.69B | 22.78B | 21.99B | 18.05B | 14.64B | 16.49B | 15.31B | 14.13B | 17.09B | 16.48B | 15.84B | 15.17B | 13.47B | 11.06B | 9.64B | 10.83B | 9.29B | 8.08B | 6.72B | 5.78B | 4.45B | 3.88B | 3.21B | 3.23B | 2.74B | 2.54B | 1.78B | 1.59B | 1.31B | 1.14B | 974.10M | 888.00M | 796.70M | 764.40M | 655.10M | 610.00M | 530.50M | 413.00M | 278.10M |
| Interest Income | 303.00M | 41.00M | 11.00M | 71.00M | 139.00M | 9.20M | 7.50M | 200.00K | 5.30M | 16.70M | 5.70M | 3.20M | 5.15M | 6.07M | 5.03M | 10.00M | 6.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 286.00M | 211.00M | 238.00M | 275.00M | 108.60M | 157.40M | 162.70M | 184.40M | 162.80M | 122.70M | 145.90M | 157.50M | 141.64M | 120.78M | 122.66M | 130.17M | 109.70M | 0.00 | 0.00 | 0.00 | 0.00 | 43.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.17B | 2.13B | 2.17B | 1.78B | 1.19B | 1.18B | 1.24B | 1.13B | 1.05B | 938.50M | 895.00M | 839.80M | 634.93M | 397.08M | 341.59M | 339.29M | 268.49M | 217.19M | 176.97M | 156.13M | 133.44M | 129.57M | 178.39M | 149.72M | 126.40M | 108.70M | 76.10M | 68.60M | 58.50M | 44.60M | 40.90M | 37.10M | 33.20M | 25.60M | 19.10M | 17.60M | 13.50M | 9.30M | 6.80M |
| EBITDA | 7.50B | 9.71B | 10.01B | 6.59B | 4.60B | 4.28B | 4.34B | 4.03B | 3.21B | 4.54B | 4.61B | 4.01B | 3.22B | 2.86B | 1.89B | 2.22B | 2.02B | 1.74B | 1.46B | 1.26B | 979.43M | 824.41M | 750.13M | 701.87M | 584.40M | 498.70M | 343.00M | 294.80M | 238.80M | 190.50M | 133.90M | 98.10M | 68.10M | 101.20M | 113.10M | 122.20M | 98.00M | 42.30M | 26.70M |
| EBITDA Ratio | 31.39% | 34.08% | 34.29% | 27.45% | 25.74% | 23.92% | 23.68% | 24.30% | 22.07% | 22.81% | 21.84% | 21.95% | 20.24% | 21.67% | 16.89% | 17.47% | 18.09% | 17.91% | 18.11% | 18.19% | 18.08% | 17.87% | 21.68% | 18.58% | 18.65% | 17.74% | 16.72% | 16.27% | 16.06% | 14.78% | 11.76% | 9.65% | 7.49% | 11.42% | 14.12% | 16.95% | 15.63% | 7.69% | 6.68% |
| Operating Income | 5.20B | 8.69B | 7.47B | 4.23B | 3.27B | 3.40B | 3.02B | 2.75B | 3.47B | 3.43B | 3.27B | 3.17B | 2.62B | 2.17B | 1.54B | 1.87B | 1.74B | 1.52B | 1.26B | 1.11B | 846.00M | 701.12M | 502.01M | 552.15M | 458.00M | 366.80M | 266.90M | 226.20M | 180.30M | 145.90M | 93.00M | 61.00M | 34.90M | 75.60M | 94.00M | 104.60M | 84.50M | 33.00M | 19.90M |
| Operating Income Ratio | 21.77% | 27.61% | 25.35% | 18.99% | 18.25% | 17.11% | 16.48% | 16.29% | 16.87% | 17.23% | 17.13% | 17.33% | 16.27% | 16.41% | 13.79% | 14.72% | 15.79% | 15.82% | 15.84% | 16.04% | 15.98% | 15.32% | 13.27% | 14.62% | 14.33% | 12.60% | 13.01% | 12.48% | 12.13% | 11.32% | 8.72% | 6.43% | 4.20% | 9.00% | 12.55% | 14.64% | 13.74% | 7.40% | 6.68% |
| Total Other Income/Expenses | -158.00M | -390.00M | 133.00M | 264.00M | 35.90M | 237.80M | -82.40M | -123.90M | -122.80M | 50.50M | 291.10M | -154.30M | -289.95M | 176.33M | -117.62M | -120.17M | -103.61M | -89.15M | -13.13M | -47.42M | -48.96M | -43.65M | -25.75M | -29.23M | -28.50M | -49.80M | -12.90M | -16.80M | -7.20M | -9.30M | -2.00M | -4.30M | -8.60M | -13.50M | -14.90M | -31.60M | -41.10M | -15.20M | -5.80M |
| Income Before Tax | 5.04B | 8.29B | 7.60B | 4.50B | 3.31B | 3.29B | 2.94B | 2.61B | 3.32B | 3.48B | 3.57B | 3.01B | 2.45B | 2.34B | 1.42B | 1.75B | 1.64B | 1.45B | 1.23B | 1.06B | 797.04M | 657.47M | 476.26M | 522.92M | 429.50M | 301.10M | 253.80M | 209.80M | 173.10M | 136.60M | 91.00M | 56.70M | 26.30M | 62.10M | 79.10M | 73.00M | 43.40M | 17.80M | 14.10M |
| Income Before Tax Ratio | 21.11% | 26.35% | 25.80% | 20.17% | 18.45% | 16.55% | 16.03% | 15.47% | 16.16% | 17.48% | 18.65% | 16.49% | 15.21% | 17.74% | 12.74% | 13.78% | 14.85% | 15.07% | 15.46% | 15.35% | 15.06% | 14.36% | 12.59% | 13.84% | 13.43% | 10.35% | 12.37% | 11.58% | 11.64% | 10.60% | 8.53% | 5.97% | 3.16% | 7.39% | 10.56% | 10.22% | 7.06% | 3.99% | 4.73% |
| Income Tax Expense | 823.00M | 1.08B | 1.25B | 849.00M | 873.00M | 641.90M | 469.00M | 457.90M | 725.30M | 883.40M | 871.00M | 711.50M | 512.56M | 549.71M | 273.15M | 431.68M | 423.10M | 324.14M | 336.64M | 311.72M | 260.20M | 223.33M | 178.60M | 198.71M | 167.90M | 118.20M | 99.00M | 81.80M | 67.30M | 54.90M | 37.30M | 25.10M | 13.00M | 26.40M | 32.00M | 33.00M | 22.90M | 9.10M | 8.50M |
| Net Income | 4.76B | 7.21B | 6.43B | 3.65B | 3.01B | 2.65B | 2.49B | 2.55B | 3.36B | 2.60B | 2.70B | 2.39B | 2.17B | 1.79B | 1.15B | 1.32B | 1.37B | 1.12B | 897.80M | 746.00M | 536.83M | 290.39M | 297.67M | 324.21M | 261.60M | 182.90M | 154.80M | 207.80M | 108.40M | 81.70M | 17.70M | 31.60M | 13.30M | 35.70M | 61.10M | 39.00M | 20.10M | 8.70M | 5.60M |
| Net Income Ratio | 19.94% | 22.91% | 21.84% | 16.36% | 16.80% | 13.33% | 13.60% | 15.13% | 16.33% | 13.05% | 14.10% | 13.10% | 13.50% | 13.58% | 10.30% | 10.38% | 12.42% | 11.69% | 11.24% | 10.83% | 10.14% | 6.34% | 7.87% | 8.58% | 8.18% | 6.29% | 7.55% | 11.47% | 7.29% | 6.34% | 1.66% | 3.33% | 1.60% | 4.25% | 8.16% | 5.46% | 3.27% | 1.95% | 1.88% |
| EPS | 6.44 | 9.80 | 8.77 | 4.97 | 3.48 | 3.78 | 3.58 | 3.69 | 4.81 | 3.70 | 3.87 | 3.45 | 3.21 | 2.74 | 1.80 | 2.07 | 2.20 | 1.82 | 1.46 | 1.21 | 0.88 | 0.48 | 0.52 | 0.57 | 0.46 | 0.34 | 0.33 | 0.44 | 0.23 | 0.09 | 0.04 | 0.07 | 0.03 | 0.09 | 0.16 | 0.10 | 0.06 | 0.03 | 0.02 |
| EPS Diluted | 6.38 | 9.64 | 8.61 | 4.89 | 3.43 | 3.73 | 3.53 | 3.65 | 4.74 | 3.63 | 3.80 | 3.36 | 3.11 | 2.64 | 1.73 | 1.98 | 2.10 | 1.74 | 1.38 | 1.15 | 0.84 | 0.47 | 0.50 | 0.56 | 0.45 | 0.33 | 0.32 | 0.43 | 0.23 | 0.09 | 0.04 | 0.07 | 0.03 | 0.09 | 0.16 | 0.10 | 0.05 | 0.03 | 0.02 |
| Weighted Avg Shares Out | 736.50M | 725.10M | 714.60M | 706.20M | 715.00M | 700.60M | 695.80M | 691.20M | 698.10M | 702.20M | 696.00M | 693.40M | 676.20M | 653.20M | 641.53M | 638.72M | 622.45M | 615.97M | 617.81M | 617.93M | 613.58M | 600.90M | 574.52M | 569.88M | 567.33M | 559.26M | 571.52M | 532.27M | 471.30M | 933.23M | 442.50M | 451.43M | 443.33M | 420.00M | 376.00M | 380.49M | 365.45M | 316.36M | 320.00M |
| Weighted Avg Shares Out (Dil) | 743.10M | 737.10M | 736.80M | 718.70M | 725.50M | 710.20M | 706.10M | 699.80M | 708.50M | 716.10M | 711.00M | 713.10M | 701.20M | 683.30M | 671.48M | 671.73M | 658.92M | 650.50M | 655.97M | 655.40M | 646.28M | 633.93M | 607.39M | 582.00M | 584.36M | 575.95M | 589.38M | 544.65M | 476.48M | 933.23M | 442.50M | 451.43M | 443.33M | 420.00M | 376.00M | 390.00M | 382.86M | 348.00M | 320.00M |
Danaher Corporation (DHR) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
Danaher Corporation (NYSE:DHR ) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 3:25 PM ET Company Participants Rainer Blair - President and CEO Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Great. Thanks, everyone, for joining us...
Danaher to Present at Evercore ISI HealthCONx Conference
WASHINGTON , Nov. 26, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Wednesday, December 4, 2024 at...
Revving Up: 2 Underperforming Dividend Giants Ready To Outshine
Two high-quality dividend stocks are finally positioned for a strong rebound. After a period of underperformance, their growth potential is back in focus. These companies have adapted well to recent challenges, enhancing their strategies to boost shareholder returns. Their fundamentals...
Danaher (DHR) Reliance on International Sales: What Investors Need to Know
Examine Danaher's (DHR) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.
These seven companies are transforming steady profits into rising passive income streams for investors.
Understanding Danaher's Cautiousness
Danaher reported okay Q3 earnings, with "cautiousness" probably being the best adjective to describe the release. The company has finally returned to growth and forward-looking commentary seems positive, but management seems reluctant to put numbers around their optimism. There might...
Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating
On Tuesday, Danaher Corp DHR reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion.
Danaher Q3 Earnings Surpass Estimates, Diagnostics Sales Up Y/Y
DHR's third-quarter earnings and sales surpass estimates, benefiting from the solid performance of its Life Sciences and Diagnostics segments.
Stock Markets Taper on High Valuations, Upcoming Election
In two weeks we potentially could see a number of prominent news items which could change the trajectory of stock market enthusiasm.
Danaher Corporation (DHR) Q3 2024 Earnings Call Transcript
Danaher Corporation (NYSE:DHR ) Q3 2024 Earnings Call Transcript October 22, 2024 8:00 AM ET Company Participants John Bedford - VP of IR Rainer Blair - President and CEO Matt McGrew - EVP and CFO Conference Call Participants Tycho Peterson...
Source: https://incomestatements.info
Category: Stock Reports